CTOs on the Move

MediBeacon

www.medibeacon.com

 
MediBeacon was formed in 2012 specifically to acquire the optical diagnostic program from Mallinckrodt, the Pharmaceuticals business of Covidien. MediBeacon mission is to commercialize biocompatible optical diagnostic agents for physiological monitoring, surgical guidance, and imaging of pathological disease in the human population. Several product concepts in these arenas are contained in the MediBeacon Intellectual Property (IP) portfolio.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million
  • www.medibeacon.com
  • 1100 Corporate Square Drive Helix Center, Suite 175
    St. Louis, MO USA 63132
  • Phone: 314.269.5808

Executives

Name Title Contact Details

Funding

MediBeacon raised $22.4M on 08/27/2015

Similar Companies

Imaging3

Imaging3, Inc. is a Burbank, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Optasia Medical

Optasia Medical is a Sudbury, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Tri-anim Health Services

Tri-anim Health Services is a Dublin, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Neurolens

Modern lifestyles and persistent near vision utilization cause a majority of patients to experience the reduced visual acuity and painful symptoms of eye misalignment – headaches, eye strain, neck and shoulder pain, motion sickness and dry eye sensation. Neurolens addresses common binocular vision issues using a three-step process. Step one is efficiently identifying patient symptomology using a basic online symptom screener that every patient can complete in minutes. This information goes directly to the Neurolens Measurement Device, Gen 2—or NMD2—ready for step two, which is accurately and objectively measuring the patient`s level of misalignment. The NMD2 is an objective, accurate and repeatable way to measure eye misalignment as small as 0.01 Prism Diopters. Most importantly, step three is correcting eye misalignment with a proven lens solution. Neurolenses address binocular vision issues by providing a contoured prism lens design that gradually delivers more prism in the lens corridor from distance to near. Neurolenses are proven to have a profound impact on a patient`s visual clarity and comfort. In fact, 93% of patients responded positively to wearing Neurolenses. Over 81% of patients suffering from chronic daily headaches reported their symptoms were substantially reduced or basically gone after wearing Neurolenses for 90 days. Neurolens—recognized in 2022 as one of the 30 fastest growing private companies in the healthcare industry by Inc. Magazine—is confident that appropriately addressing growing binocular vision issues will become a standard of care in this industry, unlocking dramatic patient outcomes and practice growth.

Techreg Services

Techreg Services is a Hillsborough, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.